TrialJournal of hepatocellular carcinoma2025

Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study.

Hui-Chuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.